[go: up one dir, main page]

UY26763A1 - Inmunización del ganado lacteo con proteína gapc quimérica contra infección por estreptococo. - Google Patents

Inmunización del ganado lacteo con proteína gapc quimérica contra infección por estreptococo.

Info

Publication number
UY26763A1
UY26763A1 UY26763A UY26763A UY26763A1 UY 26763 A1 UY26763 A1 UY 26763A1 UY 26763 A UY26763 A UY 26763A UY 26763 A UY26763 A UY 26763A UY 26763 A1 UY26763 A1 UY 26763A1
Authority
UY
Uruguay
Prior art keywords
gapc
immunization
chemical
dairy cattle
protein against
Prior art date
Application number
UY26763A
Other languages
English (en)
Inventor
Jose Perez Casal
Andrew A Portter
Michael Fontain
Original Assignee
Univ Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Saskatchewan filed Critical Univ Saskatchewan
Publication of UY26763A1 publication Critical patent/UY26763A1/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Se describe aquí la producción recombinante de una proteína quimérica GapC de unión con plasmina la cual comprende toda la secuencia de aminoácidos de la proteína GapC del Estreptococo dysgalactiae, además de unas secuencias únicas de aminoácidos de las proteínas GapC del estreptococo parauberis y el estreptococo agalactiae. También se describe el empleo de la proteína quimérica GapC Gap4 en vacunas para prevenir o tratar las infecciones estreptocóccicas en general y la mastitis en particular
UY26763A 2000-06-12 2001-06-12 Inmunización del ganado lacteo con proteína gapc quimérica contra infección por estreptococo. UY26763A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21124700P 2000-06-12 2000-06-12

Publications (1)

Publication Number Publication Date
UY26763A1 true UY26763A1 (es) 2001-08-27

Family

ID=22786123

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26763A UY26763A1 (es) 2000-06-12 2001-06-12 Inmunización del ganado lacteo con proteína gapc quimérica contra infección por estreptococo.

Country Status (12)

Country Link
US (4) US6660270B2 (es)
EP (1) EP1294771B1 (es)
AR (1) AR028713A1 (es)
AT (1) ATE412673T1 (es)
CA (1) CA2411919C (es)
CY (1) CY1108724T1 (es)
DE (1) DE60136356D1 (es)
DK (1) DK1294771T3 (es)
ES (1) ES2316450T3 (es)
PT (1) PT1294771E (es)
UY (1) UY26763A1 (es)
WO (1) WO2001096379A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6833134B2 (en) * 2000-06-12 2004-12-21 University Of Saskacthewan Immunization of dairy cattle with GapC protein against Streptococcus infection
NZ538075A (en) * 2002-08-12 2006-05-26 Akzo Nobel Nv 22.5 kD Streptococcus uberis protein or immunogenic fragment thereof mixed an additional antigen that is pathogenic to cows in a vaccine to treat bovine mastitis
US20060118009A1 (en) * 2004-12-07 2006-06-08 Hubbs Jonathan W Soil conditioner
US20070048096A1 (en) * 2004-12-07 2007-03-01 Hubbs Jonathan W Soil conditioner
US9216212B2 (en) 2005-08-05 2015-12-22 University Of Massachusetts Virus-like particles as vaccines for paramyxovirus
US7951384B2 (en) * 2005-08-05 2011-05-31 University Of Massachusetts Virus-like particles as vaccines for paramyxovirus
US8012730B1 (en) * 2006-08-29 2011-09-06 The United States Of America As Represented By The Secretary Of Agriculture Specific lysis of staphylococcal pathogens by bacteriophage phi11 endolysin
EP2023143A1 (en) * 2007-08-06 2009-02-11 Boehringer Ingelheim Vetmedica Gmbh Immunogenic streptococcus proteins
US20100088957A1 (en) * 2008-10-09 2010-04-15 Hubbs Jonathan W Natural turf with binder
US20100216639A1 (en) * 2009-02-20 2010-08-26 Hubbs Jonathon W Gypsum soil conditioner
US8147849B2 (en) * 2009-02-20 2012-04-03 Novartis Ag Protective antigens for group B Streptococcus hypervirulent strains

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE459503B (sv) 1985-05-03 1989-07-10 Excorim Kommanditbolag Hybrid-dna-molekyl innefattande dna-sekvens som kodar foer protein g samt foerfarande foer framstaellning av protein g
US4954618A (en) 1986-02-14 1990-09-04 Genex Corporation Cloned streptococcal genes encoding protein G and their use to construct recombinant microorganisms to produce protein G
US5198215A (en) * 1987-06-22 1993-03-30 Noordzee Laboratorium N.V. Composition for controlling mastitis in ruminants, method for its preparation and method of treatment of ruminants
US4977082A (en) 1987-12-10 1990-12-11 University Of Florida Research Foundation, Inc. Type VI bacterial FC receptors
US5472696A (en) 1988-02-26 1995-12-05 Univ. Of Florida Research Foundation, Inc. Antigen of group B streptococci
US5237050A (en) 1989-03-29 1993-08-17 University Of Florida Research Foundation, Inc. Bacterial plasmin receptors as fibrinolytic agents
US5328996A (en) 1989-03-29 1994-07-12 University Of Florida Research Foundation, Inc. Bacterial plasmin receptors as fibrinolytic agents
US5476929A (en) 1991-02-15 1995-12-19 Uab Research Foundation Structural gene of pneumococcal protein
WO1993014198A1 (en) * 1992-01-08 1993-07-22 The Rockefeller University Multifunctional surface protein of streptococci
IL107025A0 (en) * 1992-09-16 1993-12-28 Univ Tennessee Res Corp Recombinant multivalent m protein vaccine
KR19990022742A (ko) * 1995-06-07 1999-03-25 샤르레 아. 테시에르 스트렙토코커스 속 유래의 hsp70 계열의 쇼크 단백질
AU709920B2 (en) 1995-06-08 1999-09-09 University Of Saskatchewan Camp factor of streptococcus uberis
US5863543A (en) 1996-06-05 1999-01-26 University Of Saskatchewan Camp factor of streptococcus uberis
AU2176997A (en) * 1996-03-29 1997-10-22 Nippon Zeon Co., Ltd. Novel fused protein, gene therefor, recombinant vector, recombinant virus, and its use
US6420135B1 (en) * 1996-10-31 2002-07-16 Human Genome Sciences, Inc. Streptococcus pneumoniae polynucleotides and sequences
US6485904B1 (en) * 1997-06-23 2002-11-26 Pfizer, Inc. DNA encoding a plasminogen activating protein
JP4637350B2 (ja) 1998-02-20 2011-02-23 アイディ・バイオメディカル・コーポレイション グループｂ連鎖球菌抗原
CA2356836C (en) 1998-12-23 2011-09-13 Shire Biochem Inc. Novel streptococcus antigens
US6391316B1 (en) * 1999-03-10 2002-05-21 University Of Saskatchewan Vaccine compositions comprising Haemophilus somnus transferrin-binding proteins and methods of use

Also Published As

Publication number Publication date
CA2411919A1 (en) 2001-12-20
US20080009022A1 (en) 2008-01-10
ATE412673T1 (de) 2008-11-15
US7258992B2 (en) 2007-08-21
AR028713A1 (es) 2003-05-21
DK1294771T3 (da) 2008-12-15
ES2316450T3 (es) 2009-04-16
PT1294771E (pt) 2009-01-06
US20050142615A1 (en) 2005-06-30
WO2001096379A3 (en) 2002-08-08
CA2411919C (en) 2012-07-31
DE60136356D1 (de) 2008-12-11
CY1108724T1 (el) 2014-04-09
US20040062774A1 (en) 2004-04-01
US6660270B2 (en) 2003-12-09
WO2001096379A2 (en) 2001-12-20
EP1294771B1 (en) 2008-10-29
US6875853B2 (en) 2005-04-05
US20020044928A1 (en) 2002-04-18
EP1294771A2 (en) 2003-03-26

Similar Documents

Publication Publication Date Title
CY1108724T1 (el) ΑΝΟΣΟΠΟΙΗΣΗ ΓΑΛΑΚΤΟΠΑΡΑΓΩΓΩΝ ΑΓΕΛΑΔΩΝ ΜΕ ΧΙΜΑΙΡΙΚΗ GapC ΠΡΩΤΕΪΝΗ ΕΝΑΝΤΙ ΜΟΛΥΝΣΗΣ ΣΤΡΕΠΤΟΚΟΚΚΟΥ
TR200704553T2 (tr) Streptokok antijenleri.
HUP0102304A1 (hu) B Csoportba tartozó Streptococcus antigének
NZ597769A (en) Proteins and nucleic acids from meningitis/sepsis-associated Escherichia Coli
BR0208944A (pt) quadros de leitura aberta de streptococus pneumoniae codificando os antìgenos de polipeptìdeos e seus usos
ECSP093601A (es) Proteínas derivadas del virus del síndrome de mancha blanca y sus usos
WO2023094713A3 (en) Coronavirus vaccine
PA8549801A1 (es) Vacuna de mycoplasma bovis y metodos para reducir la neumonia en animales
DK1349944T3 (da) Latensassocieret peptid af TGF-beta til at bibringe farmaceutisk aktive proteiner latens
Fernández-Montero et al. Proteomic profile and protease activity in the skin mucus of greater amberjack (Seriola dumerili) infected with the ectoparasite Neobenedenia girellae—An immunological approach
ATE362481T1 (de) Lantibiotikum
ES2070266T3 (es) Vacuna contra la infeccion por escherichia coli.
ATE437229T1 (de) Ricin-ähnliche toxine zur therapie von kreb, viraler oder parasitärer infektionen
AR121961A1 (es) Inmunoterapia con citocina
UY26764A1 (es) Inmunización del ganado lacteo con proteína gapc contra infección por estreptococo.
CR11384A (es) Proteina m de estreptococo, fragmentos inmunogenicos, acidos nucleicos y metodos de uso
WO2003091279A3 (en) COMBINATION VACCINES INCLUDING IMMUNOGENIC GapC AND CAMP FACTOR POLYPEPTIDES
UY26762A1 (es) Inmunización del ganado lacteo con proteína mig.
FR2813606B1 (fr) Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques
BRPI0417798A (pt) proteìna de membrana externa de 72 kda de brachyspira pilosicoli e usos diagnósticos e terapêuticos da mesma
ATE515270T1 (de) Phep, eine aminosäurepermease von staphylococcus aureus
EP1734050A3 (en) Immunization of dairy cattle with GapC protein against streptococcus infection
AR039461A1 (es) Vacunas combinadas que incluyen polipeptidos del factor camp y gapc inmunogenicos
TH83327A (th) การก่อภูมิคุ้มกันของวัวนมด้วยไคเมริกโปรตีน GapC ต่อการติดเชื้อ สเทรปโทคอกคัส
WO2001058471A3 (en) Novel amino acid and peptide inhibitors of staphylococcus virulence

Legal Events

Date Code Title Description
110 Patent granted

Effective date: 20140714

VENC Patent expired

Effective date: 20210612